Chronic Lymphocytic Leukemia (CLL) Clinical Trials
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess retreatment with venetoclax-obinutuzumab (VenG) in participants previously treated with fixed duration first-line (IL) therapy of venetoclax in combination with an anti-CD20 antibody +/- X (where X is any additional drug).
Chronic Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research
This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune characteristics and function (phenotype) of patients with indolent non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
ClinicalTrials.gov
There are two types of clinical studies: interventional studies (also called clinical trials) and observational studies. The unique identification code given to each clinical study upon …
CLL Clinical Trials
3 天之前 · Dedicated to addressing the unmet needs of the chronic lymphocytic leukemia (CLL) and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research, and educate providers and patients.
Chronic Lymphocytic Leukemia Clinical Trials and Research
We offer a range of clinical trials for newly-diagnosed CLL, relapsed/refractory CLL, as well as Richter's syndrome, a condition where CLL turns into an aggressive form of lymphoma. Learn more about clinical trials for CLL patients.
CLL / SLL Clinical Trial Basics - CLL Society
Dedicated to addressing the unmet needs of the chronic lymphocytic leukemia (CLL) and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research, and educate providers and patients.
UCSD Chronic Lymphocytic Leukemia Clinical Trials — San Diego
2024年11月6日 · Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess retreatment with venetoclax-obinutuzumab (VenG) in participants previously treated with fixed duration first-line (IL) therapy of venetoclax in combination with an anti-CD20 antibody +/- X (where X is any additional drug).
Research and clinical trials into chronic lymphocytic leukaemia (CLL)
Researchers around the world are looking into the causes, diagnosis and treatment of CLL. They are also looking into whether new treatments are safe and better than those currently available. Go to Cancer Research UK’s clinical trials database if you are looking for a trial for CLL in the UK.
Clinical Trials - Leukemia & Lymphoma Society
Taking part in a clinical trial may be the best treatment choice for some chronic lymphocytic leukemia (CLL) patients. Clinical trials are under way to improve remission rates for CLL. Today's standard treatments for cancer are based on earlier clinical trials.
Chronic Lymphocytic Leukemia Clinical Trials | OSUCCC - James
Learn how bench-to-bedside clinical research is being conducted at the OSUCCC – James to improve prevention, detection & treatment of Chronic Lymphocytic Leukemia.